Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Snowberry is a New Zealand-based skincare and dermatological research company that focuses on high-performance anti-aging treatments. The company is notable for its integration of natural New Zealand botanicals with advanced peptide science, specifically its proprietary Cu-PEP (copper peptide) delivery technology. Founded in 2007 by Soraya Hendesi, Snowberry emphasizes clinical validation and sustainability, operating its own carbon-neutral plantation for ingredient sourcing. In 2018, the company was acquired by Procter & Gamble (P&G) to serve as a cornerstone of its prestige beauty and health division. Snowberry's products are designed to stimulate skin regeneration and address signs of photoaging through scientifically-backed formulations.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Snowberry.